2,4,6-triamino-5-chloroquinazoline has been researched along with diaveridine in 1 studies
Studies (2,4,6-triamino-5-chloroquinazoline) | Trials (2,4,6-triamino-5-chloroquinazoline) | Recent Studies (post-2010) (2,4,6-triamino-5-chloroquinazoline) | Studies (diaveridine) | Trials (diaveridine) | Recent Studies (post-2010) (diaveridine) |
---|---|---|---|---|---|
5 | 0 | 0 | 52 | 0 | 19 |
Protein | Taxonomy | 2,4,6-triamino-5-chloroquinazoline (IC50) | diaveridine (IC50) |
---|---|---|---|
Dihydrofolate reductase | Homo sapiens (human) | 0.53 | |
Dihydrofolate reductase | Neisseria gonorrhoeae | 0.53 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.0707 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium berghei ANKA | 0.21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Battershell, C; Hopfinger, AJ; Malhotra, D | 1 |
1 other study(ies) available for 2,4,6-triamino-5-chloroquinazoline and diaveridine
Article | Year |
---|---|
Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
Topics: Chemical Phenomena; Chemistry, Physical; Folic Acid Antagonists; Models, Molecular; Molecular Conformation; Quinazolines; Structure-Activity Relationship | 1981 |